News
BBLG
1.240
+6.90%
0.080
Weekly Report: what happened at BBLG last week (0323-0327)?
Weekly Report · 5d ago
Weekly Report: what happened at BBLG last week (0316-0320)?
Weekly Report · 03/23 10:12
Weekly Report: what happened at BBLG last week (0309-0313)?
Weekly Report · 03/16 10:11
Bone Biologics files prospectus supplement for USD 1.06 million at-the-market stock offering
Reuters · 03/13 20:36
Weekly Report: what happened at BBLG last week (0302-0306)?
Weekly Report · 03/09 10:11
Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $22.20/Share Price Valuation
Benzinga · 03/03 18:07
Bone Biologics posts FY 2025 interest income of USD 122.0k (+119.2%)
Reuters · 03/02 21:36
Weekly Report: what happened at BBLG last week (0223-0227)?
Weekly Report · 03/02 10:10
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 02/24 21:05
Weekly Report: what happened at BBLG last week (0216-0220)?
Weekly Report · 02/23 10:11
Weekly Report: what happened at BBLG last week (0209-0213)?
Weekly Report · 02/16 10:10
Weekly Report: what happened at BBLG last week (0202-0206)?
Weekly Report · 02/09 10:12
Weekly Report: what happened at BBLG last week (0126-0130)?
Weekly Report · 02/02 10:12
Weekly Report: what happened at BBLG last week (0119-0123)?
Weekly Report · 01/26 10:11
Weekly Report: what happened at BBLG last week (0112-0116)?
Weekly Report · 01/19 10:17
Weekly Report: what happened at BBLG last week (0105-0109)?
Weekly Report · 01/12 10:16
Bone Biologics summarizes key milestones achieved during 2025
TipRanks · 01/08 13:40
Weekly Report: what happened at BBLG last week (1229-0102)?
Weekly Report · 01/05 10:11
Weekly Report: what happened at BBLG last week (1222-1226)?
Weekly Report · 12/29/2025 10:10
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 12/23/2025 21:05
More
Webull provides a variety of real-time BBLG stock news. You can receive the latest news about Bone Biologics Corp through multiple platforms. This information may help you make smarter investment decisions.
About BBLG
Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.